The tumor microenvironment (TME) play critical roles in tumor survival, progression, and
metastasis and can be considered potential targets for molecular imaging of cancer. The …

Immunotherapy has transformed the treatment landscape of many cancers, with durable
responses in disease previously associated with a poor prognosis. Patient selection remains …

The innate immune system plays a key role as the first line of defense in various human
diseases including cancer, cardiovascular and inflammatory diseases. In contrast to tissue …

Immunotherapy is an effective therapeutic option for several cancers. In the last years, the
introduction of checkpoint inhibitors (ICIs) has shifted the therapeutic landscape in oncology …

The tumor heterogeneity, which leads to individual variations in tumor microenvironments,
causes poor prognoses and limits therapeutic response. Emerging technology such as …

During the past several decades, numerous studies have provided insights into biological
characteristics of cancer cells and identified various hallmarks of cancer acquired in the …

Pancreatic cancer is difficult to diagnose at the initial stage and is often discovered after
metastasis to nearby organs. Gemcitabine is currently used as a standard treatment for …

Natural killer (NK) cells are an important arm of the innate immune system. They
constitutively express the NKp30 receptor. NKp30‐mediated responses are triggered by the …

In systemic mastocytosis (SM), the clinical features and survival vary greatly. Patient-related
factors determining the outcome in SM are largely unknown. Methods: We examined the …

Simple Summary Tracking therapeutic cells with non-invasive imaging methods has the
potential to provide important information on the efficacy of cell therapies. In oncology, for …